TIDMTLI 
 
RNS Number : 5061K 
Alternative Asset Opps PCC Ltd 
20 April 2010 
 

                  ALTERNATIVE ASSET OPPORTUNITIES PCC LIMITED 
 
                      Half-Yearly Announcement of Results 
            For the period from 1 September 2009 to 28 February 2010 
 
 
 
At a meeting of the Board of Directors held on 20 April 2010, the half yearly 
accounts for the Company for the period 1 September 2009 to 28 February 2010 
were approved, details of which are attached. 
 
The financial information set out in this announcement does not constitute the 
Company's statutory accounts for the period 1 September 2009 to 28 February 
2010, but is derived from those accounts. Printed accounts for the period 1 
September 2009 to 28 February 2010 will be delivered to Shareholders during May 
2010. 
 
The financial statements have been prepared in accordance with International 
Financial Reporting Standards (IFRS). Whilst the financial information included 
in this preliminary announcement has been computed in accordance with IFRS, this 
announcement does not itself contain sufficient information to comply with IFRS. 
The Company will publish condensed financial statements that comply with IFRS in 
May 2010.  This announcement has been prepared using accounting policies 
consistent with those set out in the Company's half yearly report and financial 
statements for the period 1 September 2009 to 28 February 2010. 
 
 
P W I Ingram 
Company Secretary 
 
Telephone number:  020 7065 1467 
 
155 Bishopsgate 
London EC2M 3AD 
 
20 April 2010 
 
 
 
 
 
 
 
For the period from 1 September 2009 to 28 February 2010 
 
General information 
Alternative Asset Opportunities PCC Limited (the "Company") was registered on 27 
February 2004 in Guernsey, as a closed-ended protected cell company in 
accordance with the provisions of The Protected Cell Companies Ordinance, 1997 
and The Companies (Guernsey) Law, 2008. It was established with one Cell known 
as the US Traded Life Interests Fund (the "Fund") which had a planned life of 
approximately 8 years from the date of launch.  Following a Special Resolution 
passed at an Extraordinary General Meeting on 28 August 2009, the Articles of 
Incorporation were amended to move from having a fixed life in respect of the 
Company's Cell, US Traded Life Interests Fund (terminating on 31 March 2012) to 
offering shareholders annual continuation votes from the Company's 2012 Annual 
General Meeting onward. 
 
With effect from 1 September 2009, the Company has been managed with a view to 
being approved as an Investment Trust within the meaning of the Taxes Act, and 
has been resident in the UK for tax purposes from that date. 
 
Investment objective 
The Company's objective in respect of the Fund is to provide investors with an 
attractive capital return through investment predominantly in a diversified 
portfolio of U.S. Traded Life Interests ("TLIs"). 
 
 
 
 
 
 
 
 
 
For the period from 1 September 2009 to 28 February 2010 
 
+---------------------------------+---------------------------------+ 
| Directors                       | Registrar                       | 
| CPG Tracy (Chairman)            | Capita Registrars (Guernsey)    | 
| DIW Reynolds (Chairman of the   | Limited                         | 
| Audit Committee)                | Longue Hougue House             | 
| JPHS Scott (appointed 22        | St Sampson                      | 
| October 2009)                   | Guernsey, GY1 3US               | 
| SM Zein (appointed 1 September  |                                 | 
| 2009)                           |                                 | 
+---------------------------------+---------------------------------+ 
| Registered Office               | Investment Manager              | 
| Dorey Court, Admiral Park       | SL Investment Management        | 
| St Peter Port                   | Limited                         | 
| Guernsey, GY1 3BG               | 8/11 Grosvenor Court            | 
|                                 | Foregate Street                 | 
|                                 | Chester, CH1 1HG                | 
|                                 |                                 | 
+---------------------------------+---------------------------------+ 
| Manager                         | Banker and Custodian            | 
| RCM (UK) Limited                | Kleinwort Benson (Guernsey)     | 
| 155 Bishopsgate                 | Limited                         | 
| London, EC2M 3AD                | Dorey Court, Admiral Park       | 
|                                 | St Peter Port                   | 
|                                 | Guernsey, GY1 3BG               | 
+---------------------------------+---------------------------------+ 
| Secretary                       | Sub Custodian                   | 
| RCM (UK) Limited                | Wells Fargo Bank Northwest N.A. | 
| 155 Bishopsgate                 | 299 South Main Street           | 
| London EC2M 3AD                 | 12th Floor                      | 
|                                 | Salt Lake City                  | 
| Represented by PWI Ingram FCIS  | UT 84111-2263                   | 
|                                 |                                 | 
+---------------------------------+---------------------------------+ 
| Administrator                   | Legal Advisers (Guernsey)       | 
| Kleinwort Benson (Channel       | Carey Olsen                     | 
| Islands)                        | Carey House                     | 
| Fund Services Limited           | Les Banques                     | 
| Dorey Court, Admiral Park       | St Peter Port                   | 
| St Peter Port                   | Guernsey, GY1 4BZ               | 
| Guernsey, GY1 3BG               |                                 | 
|                                 |                                 | 
+---------------------------------+---------------------------------+ 
| Legal Advisers (UK)             | Auditors                        | 
| Herbert Smith LLP               | Deloitte LLP                    | 
| Exchange House                  | Regency Court                   | 
| Primrose Street                 | Glategny Esplanade              | 
| London, EC2A 2HS                | St Peter Port                   | 
|                                 | Guernsey, GY1 3HW               | 
|                                 |                                 | 
+---------------------------------+---------------------------------+ 
| Financial Adviser and Corporate |                                 | 
| Broker                          |                                 | 
| RBS Hoare Govett Limited        |                                 | 
| 250 Bishopsgate                 |                                 | 
| London EC2M 4AA                 |                                 | 
|                                 |                                 | 
+---------------------------------+---------------------------------+ 
 
 
 
INVESTOR INFORMATION (CONTINUED) 
For the period from 1 September 2009 to 28 February 2010 
 
Directors 
The Directors have been chosen for their investment and commercial experience 
and are listed below: 
 
Charles Tracy, Chairman, (aged 64) has over 30 years' experience as a merchant 
banker, covering both the investment management and banking fields. On joining 
N.M. Rothschild & Sons in 1975 he was made responsible for Asian and 
commodity-related investments, working in Malaysia and Hong Kong before taking 
up the post of Managing Director of N.M. Rothschild & Sons (C.I.) Ltd. in 1981, 
and remaining in that position until 1998. During that period he was Chairman of 
the Association of Guernsey Banks and of the Guernsey International Business 
Association. He is currently non-executive Chairman of Louvre Fund Management 
Limited and the President of the Guernsey Tax Tribunal. He is a resident of 
Guernsey. 
 
Ian Reynolds (aged 66) is a former Chief Executive of Commercial Union Life 
Assurance Company. He is a director of Liverpool Victoria Friendly Society and a 
former consultant actuary at Towers Perrin. Mr Reynolds is a Fellow of the 
Institute of Actuaries and a Chartered Director. He is UK resident. 
 
John Scott (aged 57) was appointed a Director on 22 October 2009.   He is 
currently a director of several UK investment trusts and is Chairman of Scottish 
Mortgage and of Dunedin Income Growth.  Mr Scott held a number of senior 
appointments at Lazard Brothers & Co., Limited.  Prior to that, he worked at 
Jardine Matheson & Co., Limited.  He is a Fellow of the Chartered Insurance 
Institute and of the Chartered Institute for Securities and Investment. He is UK 
resident. 
 
Saad Zein (43) was appointed a Director on 1 September 2009.  Mr Zein is a 
Senior Managing Director of Aladdin Capital Management UK LLP.  Prior to this, 
his career has been spent as an investment banker with particular focus on 
credit markets and structured products, including US traded life interests.  He 
was employed by Dresdner Kleinwort Wasserstein between 1999 and 2009, where he 
held a number of senior positions.   He is UK resident. 
 
The Investment Manager 
The Investment Manager, SL Investment Management Limited, which is authorised 
and regulated in the United Kingdom by the Financial Services Authority, was 
formed in 1990 and is an investment adviser for a range of specialist investment 
products. 
 
The Investment Manager is responsible for managing the TLI portfolio. 
 
The Manager 
RCM (UK) Limited is part of RCM, a global asset management company operating 
from six international offices-San Francisco, London, Frankfurt, Hong Kong, 
Tokyo and Sydney.  Through its predecessors RCM (UK) Limited has a heritage of 
investment trust management expertise in the UK reaching back to the nineteenth 
century and at 31 March 2010 it had GBP1.06 billion of assets under management 
in a range of investment trusts.   RCM (UK) Limited is authorised and regulated 
by the Financial Services Authority. 
 
RCM is a company of Allianz Global Investors which, with GBP1,046 billion of 
assets under management at 31 December 2009, is one of the largest global asset 
management groups. 
 
The Manager is responsible for managing the cash and fixed interest holdings of 
the Fund during its life, and foreign currency hedging. 
 
 
 
 
RESPONSIBILITY STATEMENT 
For the period from 1 September 2009 to 28 February 2010 
 
We confirm to the best of our knowledge 
 
a. the half yearly report and unaudited condensed financial statements have been 
prepared in accordance with IAS 34; 
b. the interim management report (contained in the Chairman's Statement, 
Investment Manager's Report and Manager's Report) includes a fair review of the 
information required by DTR 4.2.7R (indication of important events during the 
first six months and description of principal risks and uncertainties for the 
remaining six months of the year); and 
c. the interim management report includes a fair review of the information 
required by DTR 4.2.8R (disclosure of related party transactions and changes 
therein). 
 
 
 
By order of the Board 
 
 
DIW ReynoldsJPHS Scott 
Director Director 
 
 
 
 
 
 
20 April 2010 
 
 
 
 
 
 
 
 
 
+----+----+----+----+----------+------+----------+-------------+----------+----------+-------------+----------+-------------+ 
| FINANCIAL         |          |      |          |             |          |          |             |          |             | 
| HIGHLIGHTS        |          |      |          |             |          |          |             |          |             | 
+-------------------+----------+------+----------+-------------+----------+----------+-------------+----------+-------------+ 
| For the period 1 September 2009 to 28 February 2010          |          |          |             |          |             | 
+--------------------------------------------------------------+----------+----------+-------------+----------+-------------+ 
|    |    |    |    |          |      |          |             |          |          |             |          |             | 
+----+----+----+----+----------+------+----------+-------------+----------+----------+-------------+----------+-------------+ 
|    |    |    |    |          |      |          |    01.09.09 |          |          |    01.07.08 |          |    01.07.08 | 
+----+----+----+----+----------+------+----------+-------------+----------+----------+-------------+----------+-------------+ 
|    |    |    |    |          |      |          |          to |          |          |          to |          |          to | 
|    |    |    |    |          |      |          |    28.02.10 |          |          |    31.12.08 |          |    31.08.09 | 
+----+----+----+----+----------+------+----------+-------------+----------+----------+-------------+----------+-------------+ 
|    |    |    |    |          |      |          |          (6 |          |          |          (6 |          | (14         | 
|    |    |    |    |          |      |          |     months) |          |          |     months) |          | months)     | 
+----+----+----+----+----------+------+----------+-------------+----------+----------+-------------+----------+-------------+ 
| Shares in issue                     |          | 40,000,000  |          |          | 40,000,000  |          | 40,000,000  | 
+-------------------------------------+----------+-------------+----------+----------+-------------+----------+-------------+ 
|    |    |    |    |          |      |          |             |          |          |             |          |             | 
+----+----+----+----+----------+------+----------+-------------+----------+----------+-------------+----------+-------------+ 
| Net Assets   |    |          |      |          |  33,399,238 |          |          | 37,518,243  |          | 37,064,596  | 
| at period    |    |          |      |          |             |          |          |             |          |             | 
| end          |    |          |      |          |             |          |          |             |          |             | 
+--------------+----+----------+------+----------+-------------+----------+----------+-------------+----------+-------------+ 
|    |    |    |    |          |      |          |             |          |          |             |          |             | 
+----+----+----+----+----------+------+----------+-------------+----------+----------+-------------+----------+-------------+ 
| Net asset value per Share at period |          |       83.5p |          |          |       93.8p |          |       92.7p | 
| end (see note below)                |          |             |          |          |             |          |             | 
+-------------------------------------+----------+-------------+----------+----------+-------------+----------+-------------+ 
|              |    |          |      |          |             |          |          |             |          |             | 
+--------------+----+----------+------+----------+-------------+----------+----------+-------------+----------+-------------+ 
|    |    |    |    |          |      |          |             |          |          |             |          |             | 
+----+----+----+----+----------+------+----------+-------------+----------+----------+-------------+----------+-------------+ 
| Total deficit on ordinary           |          |     (9.17p) |          |          |     (2.14p) |          |     (3.28p) | 
| activities for the                  |          |             |          |          |             |          |             | 
+-------------------------------------+----------+-------------+----------+----------+-------------+----------+-------------+ 
| financial    |    |          |      |          |             |          |          |             |          |             | 
| period per   |    |          |      |          |             |          |          |             |          |             | 
| Share        |    |          |      |          |             |          |          |             |          |             | 
+--------------+----+----------+------+----------+-------------+----------+----------+-------------+----------+-------------+ 
|    |    |    |    |          |      |          |             |          |          |             |          |             | 
+----+----+----+----+----------+------+----------+-------------+----------+----------+-------------+----------+-------------+ 
| Revenue deficit per Share           |          |     (1.39p) |          |          |     (1.65p) |          |     (3.81p) | 
+-------------------------------------+----------+-------------+----------+----------+-------------+----------+-------------+ 
|                                     |          |             |          |          |             |          |             | 
+-------------------------------------+----------+-------------+----------+----------+-------------+----------+-------------+ 
|    |    |    |    |          |      |          |             |          |          |             |          |             | 
+----+----+----+----+----------+------+----------+-------------+----------+----------+-------------+----------+-------------+ 
|         |    |    |          |      |          |             |          |          |             |          |             | 
+---------+----+----+----------+------+----------+-------------+----------+----------+-------------+----------+-------------+ 
|                                                                         |          |             |          |             | 
+----+----+----+----+----------+------+----------+-------------+----------+----------+-------------+----------+-------------+ 
 
The half-yearly financial report has neither been audited nor reviewed by the 
Company's auditors.  The financial information for the period ended 31 August 
2009 has been extracted from the audited financial statements for that period. 
 
 
Dividends 
The Directors do not propose a dividend for the period from 1 September 2009 to 
28 February 2010. 
 
 
 
 
 
 
 
CHAIRMAN'S STATEMENT 
For the period from 1 September 2009 to 28 February 2010 
 
Introduction 
This statement covers the six months from 1 September 2009.  In contrast to the 
activity reported in my last statement, this has been a relatively quiet period. 
 
Portfolio developments 
A summary of portfolio maturities since inception is given in the following 
table: 
 
+------------------------+-----------+---------+---------+---------+ 
| Period                 |    40     |   12    |   14    |    6    | 
|                        |  months   | months  | months  | months  | 
+------------------------+-----------+---------+---------+---------+ 
| Dates                  |Inception  | 1/7/07  | 1/7/08  | 1/9/09  | 
|                        |- 30/6/07  |    -    |    -    |    -    | 
|                        |           |30/6/08  |31/8/09  |28/2/10  | 
+------------------------+-----------+---------+---------+---------+ 
| Number of policies     |    7      |    6    |    7    |    3    | 
| matured                |           |         |         |         | 
+------------------------+-----------+---------+---------+---------+ 
| Value of policies      |  $9.3m    |  $3.9m  | $14.8m  |  $7.6m  | 
| matured ($ million)    |           |         |         |         | 
+------------------------+-----------+---------+---------+---------+ 
| Total premiums paid ($ |  $18.8m   |  $9.0m  | $10.5m  |  $4.4m  | 
| million)               |           |         |         |         | 
+------------------------+-----------+---------+---------+---------+ 
 
During the six month period to 28 February 2010, 3 policy maturities were 
identified, with a total face value of US$ 7.6 million. This compares with 7 
policies with a face value of US$ 14.8 million in the 14 month period to 31 
August 2009, and 13 policies with a total face value of US$ 13.2 million, in the 
period from the Company's launch to 30 June 2008. 
 
Although it is encouraging that profits of approximately GBP1.9 million were 
recognised on policies that matured in the period, the impact of policy 
revaluations (partly due to updated LEs, as referred to below) was to reduce the 
valuation of the portfolio of policies by some GBP4.6 million.  For this reason 
the benefit of foreign exchange gains during the period from the policy 
portfolio of circa GBP3.5 million was largely negated.  The combined effect of 
these movements is recognised in the net gains on investments of GBP657,903, as 
shown in the Condensed Income Statement on page 13. 
 
A further maturity has been confirmed since 28 February 2010, with a total face 
value of US$3.1 million. 
 
As at 28 February 2010 there were a total of 136 policies in the portfolio, with 
a face value of US$ 220.8 million and a valuation of US$ 86.9 million. There 
have been no policy acquisitions since completion of the original policy 
purchase programme, but premiums continued to be payable on existing holdings, 
totalling US$ 4.3 million during the half year. 
 
The principal issues facing the Company, that is to say valuation, credit risk, 
gearing and hedging are discussed below. 
 
Valuation 
The valuation remains the best estimate of the Board and the Investment Manager 
of the current value of the portfolio based on expected future cash flows.  The 
three major components of the valuation are life expectancy (LE) assessments, 
the tables of predicted mortalities based on these life assessments and the 
discount rate (internal rate of return, or IRR) used to arrive at a present 
value of the resulting cash flow projections. 
 
Past reports have alluded to changing views on life expectancy from the main US 
life assessors. The Company has continued its stated practice of obtaining new 
LE assessments on a portion of policies in the portfolio.  To date a total of 31 
policies have been re-assessed and the results have been incorporated into 
valuations. This practice will be continued.  Although LEs have on average been 
increased for these policies, there remains no consistent trend in the LE 
outcomes. 
 
 
 
 
CHAIRMAN'S STATEMENT (continued) 
For the period from 1 September 2009 to 28 February 2010 
 
Valuation (continued) 
 
In common with many participants in this sector, rates of mortality continue to 
be significantly below those predicted. This may be due to underestimation of 
LEs, but it may also be due to the particular characteristics of the portfolio. 
Experience in the development of mortality in portfolios of TLIs is not yet 
sufficiently extensive to explain what seems to be an industry-wide pattern in 
this respect. 
 
The Company's current valuation policy uses a combination of swap yields, to 
represent market interest rates, with a risk premium, derived from actual 
trades, to arrive at an overall IRR. Swap yields have stabilised, but there has 
been insufficient trading volume to give a reliable indicator of risk premiums. 
One particular problem is that there are distressed sellers in the market who 
are prepared to make sales at discounted prices to maintain portfolio liquidity. 
 There is little reliable evidence of prices for acquisitions on a 
non-distressed basis.  Under these circumstances the Board has continued to use 
the same IRRs as at the beginning of the period for the portfolio, reflecting 
low swap yields and a high risk premium.   The risk premium currently stands at 
9.5% (weighted by value) which, given the generally high standing of the 
underlying insurers combined with the uncertainties about LEs, seems reasonable 
for this type of investment.  The Board will keep this matter under regular 
review. 
 
The table of predicted yields set out below gives shareholders the opportunity 
to see the effect on portfolio returns of a wide range of mortality assumptions. 
The Board will continue actively to monitor market information and to keep the 
valuation assumptions under review. 
 
 
+------------+----------+------------+-----------+--------+---------+------------+-----------+---------+---------+ 
|            |          |             31 December 2012              |              31 December 2016              | 
+------------+----------+-------------------------------------------+--------------------------------------------+ 
| Variation  |    LE    |  Policies  |Remaining  |  IRR5  |  IRR5   |  Policies  |Remaining  |  IRR5   |  IRR5   | 
|    in      |  change  |surviving3  |Shares in  |        |         |surviving3  |Shares in  |         |         | 
|mortality1  |(years)2  |            |  issue4   |        |         |            |  issue4   |         |         | 
+            +          +            +           +--------+---------+            +           +---------+---------+ 
|            |          |            |           | 100%6  |  70%7   |            |           |  100%6  |  70%7   | 
+------------+----------+------------+-----------+--------+---------+------------+-----------+---------+---------+ 
|       100% |  0.00    |   64.4%    |  96.4%    |11.73%  | -1.48%  |   29.5%    |  33.2%    |  9.55%  |  3.98%  | 
+------------+----------+------------+-----------+--------+---------+------------+-----------+---------+---------+ 
|        80% |  1.20    |   70.0%    |  100.0%   | 7.02%  | -5.64%  |   36.6%    |  55.7%    |  4.94%  | -0.40%  | 
+------------+----------+------------+-----------+--------+---------+------------+-----------+---------+---------+ 
|        50% |  4.12    |   79.7%    |  100.0%   |-1.68%  |-13.31%  |   51.7%    |  100.0%   | -3.84%  | -8.73%  | 
+------------+----------+------------+-----------+--------+---------+------------+-----------+---------+---------+ 
|        30% |  8.00    |   87.1%    |  100.0%   |-9.22%  |-19.96%  |   66.1%    |  100.0%   |-19.15%  |-23.26%  | 
+------------+----------+------------+-----------+--------+---------+------------+-----------+---------+---------+ 
 
 
Notes: 
1.         The central case (100%) assumes that claims experience matches the 
valuation basis in force at 28 February 2010. The other scenarios assume the 
mortality experience is higher (e.g. 110% means that if one expects 10 deaths, 
one instead experiences 11) or lower (e.g. 80% means that if one expects 10 
deaths, one instead experiences 8). 
2.         This shows the effect of the mortality experience on the life 
expectation (in years) for an otherwise normal 80-year-old non-smoker. 
3.         The proportion of policies surviving to the specified date based on 
the portfolio as at 28 February 2010.  No allowance has been made for the 
policies that have matured after this date. 
4.         The model assumes that shares are repurchased whenever excess cash 
beyond that required for premium reserves is available.  This column represents 
the number of shares still in force and not repurchased at the relevant date. 
5.         This shows how the return varies for a shareholder holding the shares 
between 28 February 2010 and the relevant date (31 December 2012 or 31 December 
2016) based on the growth in the NAV per share. The NAV at that date was 84.3 
pence per share. 
6.         Return based on growth in NAV per share assuming valuation at the 
relevant date using the valuation basis in force at 28 February 2010. 
7.         Return based on winding up at the relevant date assuming that the net 
realised proceeds of assets is 70% of the valuation calculated in accordance 
with the valuation basis in force at 28 February 2010. 
 
 
CHAIRMAN'S STATEMENT (continued) 
For the period from 1 September 2009 to 28 February 2010 
 
Valuation (continued) 
 
In addition, the Board is providing similar information on two further bases 
(see the notes above for explanation of table headings): 
 
A.    Assume all lives are "normal" from the point of view of mortality 
expectations and ignore the implied relative health from medical underwriting. 
In common with the above figures, results are projected from the NAV per share 
as at 28 February 2010.  Note: the figures on this basis provided in the annual 
report were projected from the NAV per share calculated using the revised 
assumptions and are thus not strictly comparable. 
B.    Calculate results on the 100% mortality assumption, but projected from the 
share price at 28 February 2010 of 67.0p per share. 
 
 
+------+------------+-----------+--------+---------+------------+-----------+--------+--------+ 
|      |             31 December 2012              |            31 December 2016              | 
+------+-------------------------------------------+------------------------------------------+ 
|Base  |  Policies  |Remaining  |  IRR5  |  IRR5   |  Policies  |Remaining  |  IRR5  |  IRR5  | 
|      |surviving3  |Shares in  |        |         |surviving3  |Shares in  |        |        | 
|      |            |  issue4   |        |         |            |  issue4   |        |        | 
+      +            +           +--------+---------+            +           +--------+--------+ 
|      |            |           | 100%6  |  70%7   |            |           | 100%6  |  70%7  | 
+------+------------+-----------+--------+---------+------------+-----------+--------+--------+ 
|  A.  |   79.1%    |   100%    | 0.31%  |-11.55%  |   43.0%    |  84.0%    | 2.28%  |-2.92%  | 
+------+------------+-----------+--------+---------+------------+-----------+--------+--------+ 
|  B.  |   64.4%    |  96.4%    |21.16%  |  6.83%  |   29.5%    |  33.2%    |13.30%  | 7.53%  | 
+------+------------+-----------+--------+---------+------------+-----------+--------+--------+ 
 
 
 
Credit Risk 
There have been no major changes in the financial standing of the insurers who 
have issued the policies in the portfolio. As at the period end more than 99% of 
the Company's policies by value were issued by companies with an A.M. Best 
rating of 'A' or better. This figure has not changed significantly for some 
time. 
 
Gearing 
The Company's borrowing agreement with Allied Irish Banks has been renewed, and 
this provides the Company with the ability to borrow up to US$33,156,000 until 
31 January 2011.  The Board's intention is to pay down borrowings whenever 
possible, and during the six month period the Company's total borrowings fell 
from US$33,447,000 to US$25,156,000. 
 
Hedging 
As of 28 February 2010 the Company had sold forward net US$71,000,000 to March 
2012, representing no change over the period.  Although a little in excess of 
the Company's current net dollar position, this is consistent with projected 
dollar cash flows. 
 
Outlook 
The present state of the TLI market reinforces the Board's belief that the best 
approach is to hold policies to maturity rather than seek early liquidation. 
 
 
 
 
 
 
 
CPG Tracy 
Chairman 
20 April 2010 
 
INVESTMENT MANAGER'S REVIEW 
For the period from 1 September 2009 to 28 February 2010 
 
Market Review 
 
Trading volumes remain at very low levels in the Life Settlements ("LS") market. 
  The few active investors are smaller opportunistic buyers seeking out the 
highest quality investments from the abundant supply of policies.  Supply 
volumes are supported by both distressed sellers and those looking to increase 
liquidity by boosting premium reserves, which have in many cases been 
diminishing as a result of lower than expected maturities. 
 
The policies most in demand correspond closely to those held within AAO's 
portfolio and are those deemed to be "plain vanilla" and typically possessing 
the following characteristics: 
 
·      Death benefits less than $5m 
·      Life companies with a minimum AM Best rating of A 
·      Lives aged between 75 and 85 
·      Life expectancies between 5 and 10 years 
·      Low disparity between medical underwriters' life expectancy estimates 
 
 
The prices achieved for policies of this type in the current depressed market 
correspond to IRRs of between 14% and 16%;  there is virtually no appetite for 
premium financed policies or those involving beneficial interest programmes. 
 
None of the constituents of the AAO portfolio is premium financed nor is 
involved in a beneficial interest programme.  99.8% of the portfolio is split 
across Life Companies currently possessing an AM Best rating of A or higher. 
The investments in the AAO portfolio were carefully selected in accordance with 
the Company's Investment Objective and Policy ensuring a high quality portfolio 
composition. 
 
 
Investment Portfolio Review 
 
During the six-month period from 1 September 2009 to 28 February 2010 three 
policy maturities (one woman and two men) were confirmed, releasing $7.6m in 
death benefits. These maturities were announced in the previous report and there 
have since been no further incidences.  As at 28 February 2010, 136 policies 
were in the Fund's portfolio secured on 115 individual lives.  A further 
maturity has been confirmed since 28 February 2010 with a total face value of 
US43.1 million.  Proceeds from this maturity will be received in due course. 
 
From inception to 28 February 2010, there have been 23 policy maturities in 
respect of 19 lives.  Proceeds from these maturities total $36m, realising a 
$20m gain on cost (including premiums paid). 
 
The expected cost of premiums for the remaining four months of the period ending 
30 June 2010 is $2.9m and in the following accounting period ending 30 June 2011 
$9.8m, assuming no maturities during this time. 
 
INVESTMENT MANAGER'S REVIEW (CONTINUED) 
For the period from 1 September 2009 to 28 February 2010 
 
Portfolio Summary 
 
+---------------------------------+---------------------------------+ 
| Death Benefits                  |                           $221m | 
+---------------------------------+---------------------------------+ 
| Investment Value                |                            $87m | 
+---------------------------------+---------------------------------+ 
| Male / Female Ratio             |                       64% / 36% | 
+---------------------------------+---------------------------------+ 
| Number of Holding Life          |                              31 | 
| Companies                       |                                 | 
+---------------------------------+---------------------------------+ 
 
Averages weighted by Death Benefits 
 
+---------------------------------+---------------------------------+ 
| Age at purchase                 |                      82.2 years | 
+---------------------------------+---------------------------------+ 
| Age at valuation                |                      86.7 years | 
+---------------------------------+---------------------------------+ 
| Pricing Life Expectancy at      |                       7.6 years | 
| purchase                        |                                 | 
+---------------------------------+---------------------------------+ 
| Current Life Expectancy         |                       5.2 years | 
+---------------------------------+---------------------------------+ 
 
Life Group (Parent Company) Distribution (Top 5) 
 
+--------------+------------------+----------------+----------------+ 
| Ranking by   | Parent Company   |  % Total Death |   % Investment | 
| Valuation    |                  |       Benefits |          Value | 
+--------------+------------------+----------------+----------------+ 
| 1            | Lincoln          |          19.4% |          16.1% | 
|              | Financial Group  |                |                | 
+--------------+------------------+----------------+----------------+ 
| 2            | AIG Life Group   |          16.3% |          16.0% | 
+--------------+------------------+----------------+----------------+ 
| 3            | AEGON USA Group  |          12.3% |          13.3% | 
+--------------+------------------+----------------+----------------+ 
| 4            | Manulife         |           8.6% |           9.1% | 
|              | Financial Group  |                |                | 
+--------------+------------------+----------------+----------------+ 
| 5            | MassMutual       |           9.1% |           9.0% | 
|              | Financial Group  |                |                | 
+--------------+------------------+----------------+----------------+ 
 
Credit Quality Distribution by Holding Life Company 
 
+----------------------+----------------------+----------------------+ 
| AM Best Rating       |        % Total Death |   % Investment Value | 
|                      |             Benefits |                      | 
+----------------------+----------------------+----------------------+ 
| A++                  |                12.6% |                12.5% | 
+----------------------+----------------------+----------------------+ 
| A+                   |                46.6% |                43.5% | 
+----------------------+----------------------+----------------------+ 
| A                    |                40.6% |                43.8% | 
+----------------------+----------------------+----------------------+ 
| A-                   |                 0.1% |                 0.1% | 
+----------------------+----------------------+----------------------+ 
| B++                  |                 0.0% |                 0.0% | 
+----------------------+----------------------+----------------------+ 
| B+                   |                 0.1% |                 0.1% | 
+----------------------+----------------------+----------------------+ 
 
Minimum rating in portfolio: B+ 
 
Conclusion 
 
The Company's portfolio of TLIs is valued at Directors' discretion using swap 
yields plus a margin.  Although interest rates have fallen, the rate being 
applied to policies has not changed during the period, meaning the margin has 
effectively been increased. 
 
A further batch of policies has been selected for the rolling programme of 
updating life expectancies and the effect of updated assessments will be 
incorporated into the values in due course. 
 
 
 
SL Investment Management Limited 
 
20 April 2010 
 
 
 
 
 
 
MANAGER'S REVIEW 
For the period from 1 September 2009 to 28 February 2010 
 
Borrowings and Investments 
 
In February 2010 the Company renewed the borrowing arrangements with Allied 
Irish Banks.  As before, there are two elements, both now expiring on 31 January 
2011.   The first part is an amortising term loan facility of US$23,156,000 and 
the second part is a revolving credit facility ("RCF") of US$10 million.  This 
arrangement should cover the Company's funding requirement until early 2011. 
As at 28 February 2010 the amortising term loan facility was fully utilised, and 
US$2 million had been drawn down under the RCF. 
 
The primary covenant requires the Company to maintain cover (i.e. asset value, 
subject to certain adjustments, divided by borrowing) above 2.5 times. As at 28 
February 2010 cover was 3.2 times. 
 
In September 2009, the Company bought a GBP100,000 holding of the UK Treasury 4% 
2016 gilt in order to generate UK securities income. 
 
Currency Hedging 
 
The Company hedges its US dollar exposure by means of forward sales of US 
dollars. As at 28 February 2010 there were twelve outstanding forward foreign 
exchange contracts for the sale of US$78.5 million against sterling contracts 
maturing 30 March 2012 and one contract for the purchase of US$7.5 million 
against a sterling contract maturing 30 March 2012.  This was consistent with 
cash flows up to that date. 
 
The net unrealised loss on these positions amounted to GBP8,720,808, and once 
the unrealised FX profit on the underlying policies, denominated in US dollars, 
is taken into account, there was a total unrealised net loss on the Company's FX 
positions equivalent to 2.7 pence per share. 
 
 
 
RCM (UK) Limited 
 
20 April 2010 
 
 
 
 
 
 
 
CONDENSED INCOME STATEMENT 
For the period from 1 September 2009 to 28 February 2010 
 
+--------------------+-------+---------------+-------------+-------------------+-----------+--------------+--------------+-------------+--------------+--------------+ 
|                    |       |              01.09.09 to 28.02.10               |          01.07.08 to 31.12.08           |           01.07.08 to 31.08.09            | 
+--------------------+-------+-------------------------------------------------+-----------------------------------------+-------------------------------------------+ 
|                    |Notes  |    Revenue    |  Capital    |      Total        |  Revenue  |   Capital    |    Total     |  Revenue    |   Capital    |    Total     | 
+--------------------+-------+---------------+-------------+-------------------+-----------+--------------+--------------+-------------+--------------+--------------+ 
|                    |       |      GBP      |    GBP      |        GBP        |    GBP    |     GBP      |     GBP      |    GBP      |     GBP      |     GBP      | 
+--------------------+-------+---------------+-------------+-------------------+-----------+--------------+--------------+-------------+--------------+--------------+ 
| Operating income   |       |               |             |                   |           |              |              |             |              |              | 
+--------------------+-------+---------------+-------------+-------------------+-----------+--------------+--------------+-------------+--------------+--------------+ 
| Net gains on       |  9    |             - |     657,903 |           657,903 |         - |  17,084,221  |  17,084,221  |       -     |   10,484,688 |   10,484,688 | 
| investments        |       |               |             |                   |           |              |              |             |              |              | 
+--------------------+-------+---------------+-------------+-------------------+-----------+--------------+--------------+-------------+--------------+--------------+ 
| Other foreign      |13&15  |             - | (3,767,766) |       (3,767,766) |         - | (17,280,572) | (17,280,572) |       -     | (10,270,908) | (10,270,908) | 
| exchange losses    |       |               |             |                   |           |              |              |             |              |              | 
+--------------------+-------+---------------+-------------+-------------------+-----------+--------------+--------------+-------------+--------------+--------------+ 
| Interest and       |  3    |         1,978 |       -     |             1,978 |   21,094  |        -     |      21,094  |      6,543  |        -     |       6,543  | 
| similar income     |       |               |             |                   |           |              |              |             |              |              | 
+--------------------+-------+---------------+-------------+-------------------+-----------+--------------+--------------+-------------+--------------+--------------+ 
|                    |       |               |             |                   |           |              |              |             |              |              | 
+--------------------+-------+---------------+-------------+-------------------+-----------+--------------+--------------+-------------+--------------+--------------+ 
| Operating expenses |       |               |             |                   |           |              |              |             |              |              | 
+--------------------+-------+---------------+-------------+-------------------+-----------+--------------+--------------+-------------+--------------+--------------+ 
| Management fee     |  4    |      (73,199) |       -     |          (73,199) | (114,443) |        -     |    (114,443) |   (197,745) |        -     |    (197,745) | 
+--------------------+-------+---------------+-------------+-------------------+-----------+--------------+--------------+-------------+--------------+--------------+ 
| Investment         |  4    |      (86,565) |       -     |          (86,565) | (120,808) |        -     |    (120,808) |   (217,755) |        -     |    (217,755) | 
| manager's fee      |       |               |             |                   |           |              |              |             |              |              | 
+--------------------+-------+---------------+-------------+-------------------+-----------+--------------+--------------+-------------+--------------+--------------+ 
| Custodian fee      |       |       (8,656) |       -     |           (8,656) |   (9,580) |        -     |      (9,580) |    (21,708) |        -     |     (21,708) | 
+--------------------+-------+---------------+-------------+-------------------+-----------+--------------+--------------+-------------+--------------+--------------+ 
| Other expenses     |  5    | (175,211)     |       -     | (175,211)         | (138,022) |        -     |    (138,022) |   (535,069) |        -     |    (535,069) | 
+--------------------+-------+---------------+-------------+-------------------+-----------+--------------+--------------+-------------+--------------+--------------+ 
|                    |       |               |             |                   |           |              |              |             |              |              | 
+--------------------+-------+---------------+-------------+-------------------+-----------+--------------+--------------+-------------+--------------+--------------+ 
| Total operating    |       |               |             |                   |           |              |              |             |              |              | 
| expenses           |       |               |             |                   |           |              |              |             |              |              | 
+--------------------+-------+---------------+-------------+-------------------+-----------+--------------+--------------+-------------+--------------+--------------+ 
| before finance     |       |     (343,631) |       -     |         (343,631) | (382,853) |        -     |    (382,853) |   (972,277) |        -     |    (972,277) | 
| costs              |       |               |             |                   |           |              |              |             |              |              | 
+--------------------+-------+---------------+-------------+-------------------+-----------+--------------+--------------+-------------+--------------+--------------+ 
|                    |       |               |             |                   |           |              |              |             |              |              | 
+--------------------+-------+---------------+-------------+-------------------+-----------+--------------+--------------+-------------+--------------+--------------+ 
| Operating          |       |               |             |                   |           |              |              |             |              |              | 
| (loss)/profit      |       |               |             |                   |           |              |              |             |              |              | 
+--------------------+-------+---------------+-------------+-------------------+-----------+--------------+--------------+-------------+--------------+--------------+ 
| before finance     |       |     (341,653) | (3,109,863) |       (3,451,516) | (361,759) |   (196,351)  |    (588,110) |   (965,734) |      213,780 |    (751,954) | 
| costs              |       |               |             |                   |           |              |              |             |              |              | 
+--------------------+-------+---------------+-------------+-------------------+-----------+--------------+--------------+-------------+--------------+--------------+ 
|                    |       |               |             |                   |           |              |              |             |              |              | 
+--------------------+-------+---------------+-------------+-------------------+-----------+--------------+--------------+-------------+--------------+--------------+ 
| Finance costs      |       |               |             |                   |           |              |              |             |              |              | 
+--------------------+-------+---------------+-------------+-------------------+-----------+--------------+--------------+-------------+--------------+--------------+ 
| Loan Interest      |  12   |     (213,841) |       -     |         (213,841) | (299,352) |        -     |    (299,352) |   (559,155) |        -     |    (559,155) | 
| payable            |       |               |             |                   |           |              |              |             |              |              | 
+--------------------+-------+---------------+-------------+-------------------+-----------+--------------+--------------+-------------+--------------+--------------+ 
|                    |       |               |             |                   |           |              |              |             |              |              | 
+--------------------+-------+---------------+-------------+-------------------+-----------+--------------+--------------+-------------+--------------+--------------+ 
| Net                |       |     (555,494) | (3,109,863) |       (3,665,357) | (661,111) |   (196,351)  |    (857,462) | (1,524,889) |      213,780 |  (1,311,109) | 
| (deficit)/return   |       |               |             |                   |           |              |              |             |              |              | 
+--------------------+-------+---------------+-------------+-------------------+-----------+--------------+--------------+-------------+--------------+--------------+ 
|                    |       |               |             |                   |           |              |              |             |              |              | 
+--------------------+-------+---------------+-------------+-------------------+-----------+--------------+--------------+-------------+--------------+--------------+ 
| (Deficit)/Return   |  7    |       (1.39p) |     (7.78p) |           (9.17p) |   (1.65p) |      (0.49p) |      (2.14p) |     (3.81p) |        0.53p |      (3.28p) | 
| per share          |       |               |             |                   |           |              |              |             |              |              | 
+--------------------+-------+---------------+-------------+-------------------+-----------+--------------+--------------+-------------+--------------+--------------+ 
 
The revenue column of this statement is the revenue account of the Company.  All 
revenue and capital items in the above statement derive from continuing 
operations.   The notes on pages 18 to 24 are an integral part of these 
condensed financial statements. 
 
 
 
 
CONDENSED BALANCE SHEET 
As at 28 February 2010 
 
+-------------------------------------+-------+-------------+----------------+---------------+ 
|                                     |Notes  |  28.02.10   |    31.12.08    |   31.08.09    | 
+-------------------------------------+-------+-------------+----------------+---------------+ 
|                                     |       |    GBP      |      GBP       |      GBP      | 
+-------------------------------------+-------+-------------+----------------+---------------+ 
|                                     |       |             |                |               | 
+-------------------------------------+-------+-------------+----------------+---------------+ 
| Non-current assets                  |       |             |                |               | 
+-------------------------------------+-------+-------------+----------------+---------------+ 
| Financial assets at fair value      |  9    |  57,139,943 |    66,051,919  |   58,253,174  | 
| through profit or loss              |       |             |                |               | 
+-------------------------------------+-------+-------------+----------------+---------------+ 
|                                     |       |  57,139,943 |    66,051,919  |   58,253,174  | 
+-------------------------------------+-------+-------------+----------------+---------------+ 
| Current assets                      |       |             |                |               | 
+-------------------------------------+-------+-------------+----------------+---------------+ 
| Cash and cash equivalents           |       |   1,646,457 |       397,196  |      903,849  | 
+-------------------------------------+-------+-------------+----------------+---------------+ 
| Other receivables                   |  10   |      17,451 |     4,104,515  |    4,621,059  | 
+-------------------------------------+-------+-------------+----------------+---------------+ 
|                                     |       |             |                |               | 
+-------------------------------------+-------+-------------+----------------+---------------+ 
|                                     |       |   1,663,998 |     4,501,711  |    5,524,908  | 
+-------------------------------------+-------+-------------+----------------+---------------+ 
|                                     |       |             |                |               | 
+-------------------------------------+-------+-------------+----------------+---------------+ 
| Total assets                        |       |  58,803,941 |    70,553,630  |   63,778,082  | 
+-------------------------------------+-------+-------------+----------------+---------------+ 
|                                     |       |             |                |               | 
+-------------------------------------+-------+-------------+----------------+---------------+ 
| Current liabilities                 |       |             |                |               | 
+-------------------------------------+-------+-------------+----------------+---------------+ 
| Loan account                        |  12   |  16,509,166 |    21,874,359  |   20,557,471  | 
+-------------------------------------+-------+-------------+----------------+---------------+ 
| Fair value of forward foreign       |  15   |   8,720,808 | 10,953,819     | 5,720,617     | 
| exchange contracts                  |       |             |                |               | 
+-------------------------------------+-------+-------------+----------------+---------------+ 
| Other payables                      |  11   |     174,728 |       207,209  |      435,398  | 
+-------------------------------------+-------+-------------+----------------+---------------+ 
|                                     |       |             |                |               | 
+-------------------------------------+-------+-------------+----------------+---------------+ 
| Total liabilities                   |       |  25,404,702 |    33,035,387  |   26,713,486  | 
+-------------------------------------+-------+-------------+----------------+---------------+ 
|                                     |       |             |                |               | 
+-------------------------------------+-------+-------------+----------------+---------------+ 
|                                     |       |             |                |               | 
+-------------------------------------+-------+-------------+----------------+---------------+ 
| Net assets attributable to          |       |  33,399,239 |    37,518,243  |   37,064,596  | 
| shareholders                        |       |             |                |               | 
+-------------------------------------+-------+-------------+----------------+---------------+ 
|                                     |       |             |                |               | 
+-------------------------------------+-------+-------------+----------------+---------------+ 
| Shareholders' funds                 |       |             |                |               | 
+-------------------------------------+-------+-------------+----------------+---------------+ 
| Share premium account               |       | 39,168,236  |    39,168,236  |   39,168,236  | 
+-------------------------------------+-------+-------------+----------------+---------------+ 
| Reserves                            |  13   | (5,768,997) |   (1,649,993)  |   (2,103,640) | 
+-------------------------------------+-------+-------------+----------------+---------------+ 
|                                     |       |             |                |               | 
+-------------------------------------+-------+-------------+----------------+---------------+ 
| Total equity                        |       | 33,399,239  |    37,518,243  |   37,064,596  | 
+-------------------------------------+-------+-------------+----------------+---------------+ 
|                                     |       |             |                |               | 
+-------------------------------------+-------+-------------+----------------+---------------+ 
| Net asset value per share           |  8    |       83.5p |          93.8p |         92.7p | 
|                                     |       |             |                |               | 
+-------------------------------------+-------+-------------+----------------+---------------+ 
 
These financial statements were approved by the Board of Directors on 20 April 
2010. 
 
Signed on behalf of the Board. 
 
 
 
DIW Reynolds JPHS Scott 
Director Director 
 
 
 
 
 
 
 
The notes on pages 18 to 24 are an integral part of these condensed financial 
statements. 
 
CONDENSED STATEMENT OF CHANGES IN SHAREHOLDERS' FUNDS 
For the period from 1 September 2009 to 28 February 2010 
 
+----------------------------+-------------+-------------+-------------+-------------+ 
|                            |    Share    |  Capital    |  Revenue    |    Total    | 
+----------------------------+-------------+-------------+-------------+-------------+ 
|                            |  Premium    |  Reserve    |  Reserve    |             | 
+----------------------------+-------------+-------------+-------------+-------------+ 
|                            |    GBP      |    GBP      |    GBP      |    GBP      | 
+----------------------------+-------------+-------------+-------------+-------------+ 
| At 1 July 2008             | 39,168,236  |  2,175,113  | (2,967,644) | 38,375,705  | 
+----------------------------+-------------+-------------+-------------+-------------+ 
|                            |             |             |             |             | 
+----------------------------+-------------+-------------+-------------+-------------+ 
| Deficit for the period     |       -     |  (196,351)  |   (661,111) |   (857,462) | 
+----------------------------+-------------+-------------+-------------+-------------+ 
|                            |             |             |             |             | 
+----------------------------+-------------+-------------+-------------+-------------+ 
| At 31 December 2008        | 39,168,236  |  1,978,762  | (3,628,755) | 37,518,243  | 
+----------------------------+-------------+-------------+-------------+-------------+ 
|                            |             |             |             |             | 
+----------------------------+-------------+-------------+-------------+-------------+ 
| Return/(Deficit) for the   |       -     |     410,131 |   (863,778) |   (453,647) | 
| period                     |             |             |             |             | 
+----------------------------+-------------+-------------+-------------+-------------+ 
|                            |             |             |             |             | 
+----------------------------+-------------+-------------+-------------+-------------+ 
| At 31 August 2009          | 39,168,236  |  2,388,893  | (4,492,533) | 37,064,596  | 
+----------------------------+-------------+-------------+-------------+-------------+ 
|                            |             |             |             |             | 
+----------------------------+-------------+-------------+-------------+-------------+ 
| Deficit for the period     |       -     | (3,109,863) |   (555,494) | (3,665,357) | 
+----------------------------+-------------+-------------+-------------+-------------+ 
|                            |             |             |             |             | 
+----------------------------+-------------+-------------+-------------+-------------+ 
| At 28 February 2010        | 39,168,236  |   (720,970) | (5,048,027) |  33,399,239 | 
+----------------------------+-------------+-------------+-------------+-------------+ 
 
The notes on pages 18 to 24 are an integral part of these condensed financial 
statements. 
 
CONDENSED CASH FLOW STATEMENT 
For the period from 1 September 2009 to 28 February 2010 
 
 
 
+----------------------------------------+-------------+--------------+--------------+ 
|                                        |    01.09.09 |     01.07.08 |     01.07.08 | 
+----------------------------------------+-------------+--------------+--------------+ 
|                                        |          to |           to |           to | 
|                                        |    28.02.10 |     31.12.08 |     31.08.09 | 
+----------------------------------------+-------------+--------------+--------------+ 
|                                        |    GBP      |     GBP      |     GBP      | 
+----------------------------------------+-------------+--------------+--------------+ 
| Cash flows from operating activities   |             |              |              | 
+----------------------------------------+-------------+--------------+--------------+ 
| Revenue account operating loss before  |   (341,653) |    (361,759) |    (965,734) | 
| finance costs for the period           |             |              |              | 
+----------------------------------------+-------------+--------------+--------------+ 
| Decrease/(Increase) in other           |   4,603,518 | (3,861,014)  | (4,377,558)  | 
| receivables                            |             |              |              | 
+----------------------------------------+-------------+--------------+--------------+ 
| (Decrease)/Increase in other payables  |   (260,670) |   (152,564)  |      75,625  | 
+----------------------------------------+-------------+--------------+--------------+ 
| Premiums paid                          | (2,644,328) |  (2,683,369) |  (6,459,242) | 
+----------------------------------------+-------------+--------------+--------------+ 
| Purchase of investments                |   (105,430) |            - |            - | 
+----------------------------------------+-------------+--------------+--------------+ 
| Proceeds from maturity of investments  |   4,520,892 |   4,610,915  |   9,586,000  | 
+----------------------------------------+-------------+--------------+--------------+ 
| Currency losses                        |   (767,575) |    (132,787) |  (3,245,159) | 
+----------------------------------------+-------------+--------------+--------------+ 
|                                        |             |              |              | 
+----------------------------------------+-------------+--------------+--------------+ 
| Net cash inflow/(outflow) from         |   5,004,754 |  (2,580,578) |  (5,386,068) | 
| operating activities                   |             |              |              | 
+----------------------------------------+-------------+--------------+--------------+ 
|                                        |             |              |              | 
+----------------------------------------+-------------+--------------+--------------+ 
| Financing activities                   |             |              |              | 
+----------------------------------------+-------------+--------------+--------------+ 
| (Decrease)/Increase in loan account    | (4,048,305) |   2,081,030  |   5,652,976  | 
+----------------------------------------+-------------+--------------+--------------+ 
| Interest paid                          |   (213,841) |    (299,352) |    (559,155) | 
+----------------------------------------+-------------+--------------+--------------+ 
|                                        |             |              |              | 
+----------------------------------------+-------------+--------------+--------------+ 
| Net cash inflow from financing         | (4,262,146) |   1,781,678  |   5,093,821  | 
| activities                             |             |              |              | 
+----------------------------------------+-------------+--------------+--------------+ 
|                                        |             |              |              | 
+----------------------------------------+-------------+--------------+--------------+ 
| Reconciliation of cash flow to         |             |              |              | 
| movement in net cash                   |             |              |              | 
+----------------------------------------+-------------+--------------+--------------+ 
| Increase/(Decrease) in cash and cash   |     742,608 |    (798,900) |    (292,247) | 
| equivalents in the period              |             |              |              | 
+----------------------------------------+-------------+--------------+--------------+ 
| Cash and cash equivalents at the       |     903,849 |   1,196,096  |   1,196,096  | 
| beginning of the period                |             |              |              | 
+----------------------------------------+-------------+--------------+--------------+ 
|                                        |             |              |              | 
+----------------------------------------+-------------+--------------+--------------+ 
| Cash and cash equivalents at the end   |   1,646,457 |     397,196  |     903,849  | 
| of the period                          |             |              |              | 
+----------------------------------------+-------------+--------------+--------------+ 
 
 
 
 
 
 
The notes on pages 18 to 24 are an integral part of these condensed financial 
statements. 
 
PORTFOLIO OF INVESTMENTS 
As at 28 February 2010 
 
+------------------------------+----------+-------------+-----------+--------+ 
| Traded Life Interests (TLIs) |          |             |           |        | 
+------------------------------+----------+-------------+-----------+--------+ 
|                              |  Number  |             |  Portion  |  AM    | 
|                              |          |             |    of     |  Best  | 
+------------------------------+----------+-------------+-----------+--------+ 
|                              |    of    |  Valuation  |Portfolio  |Rating  | 
|                              |Policies  |             |           |        | 
+------------------------------+----------+-------------+-----------+--------+ 
| Issuer                       |          |    GBP      |    %      |        | 
+------------------------------+----------+-------------+-----------+--------+ 
| American General Life        |       13 |  9,132,099  |    15.98% | A      | 
| Insurance Company (TX)       |          |             |           |        | 
+------------------------------+----------+-------------+-----------+--------+ 
| Lincoln National Life        |       19 |  8,300,277  |    14.53% | A+     | 
| Insurance Company            |          |             |           |        | 
+------------------------------+----------+-------------+-----------+--------+ 
| Transamerica Life Insurance  |       21 |  7,611,746  |    13.32% | A      | 
| Company                      |          |             |           |        | 
+------------------------------+----------+-------------+-----------+--------+ 
| Massachusetts Mutual Life    |       10 |  5,138,375  |     8.99% | A++    | 
| Insurance Company            |          |             |           |        | 
+------------------------------+----------+-------------+-----------+--------+ 
| Aviva Life and Annuity       |        6 |  3,612,671  |     6.32% | A      | 
| Company                      |          |             |           |        | 
+------------------------------+----------+-------------+-----------+--------+ 
| John Hancock Life Insurance  |       10 |   3,546,973 |     6.21% | A+     | 
| Company                      |          |             |           |        | 
+------------------------------+----------+-------------+-----------+--------+ 
| Pacific Life Insurance       |        6 |  3,376,334  |     5.91% | A+     | 
| Company                      |          |             |           |        | 
+------------------------------+----------+-------------+-----------+--------+ 
| MetLife Insurance Company of |        8 |  2,403,994  |     4.21% | A+     | 
| Connecticut                  |          |             |           |        | 
+------------------------------+----------+-------------+-----------+--------+ 
| New York Life Insurance and  |        6 |  1,994,322  |     3.49% | A++    | 
| Annuity Corporation          |          |             |           |        | 
+------------------------------+----------+-------------+-----------+--------+ 
| Security Life of Denver      |        1 |  1,792,745  |     3.14% | A      | 
| Insurance Company            |          |             |           |        | 
+------------------------------+----------+-------------+-----------+--------+ 
| John Hancock Variable Life   |        3 |  1,663,096  |     2.91% | A+     | 
| Insurance Company            |          |             |           |        | 
+------------------------------+----------+-------------+-----------+--------+ 
| Columbus Life Insurance      |        2 |  1,106,469  |     1.94% | A+     | 
| Company                      |          |             |           |        | 
+------------------------------+----------+-------------+-----------+--------+ 
| AXA Equitable Life Insurance |        4 |    911,516  |     1.60% | A+     | 
| Company                      |          |             |           |        | 
+------------------------------+----------+-------------+-----------+--------+ 
| National Western Life        |        1 |    901,908  |     1.58% | A      | 
| Insurance Company            |          |             |           |        | 
+------------------------------+----------+-------------+-----------+--------+ 
| Lincoln Life & Annuity       |        2 |    881,134  |     1.54% | A+     | 
| Company of NY                |          |             |           |        | 
+------------------------------+----------+-------------+-----------+--------+ 
| MONY Life Insurance Company  |        1 |    792,477  |     1.39% | A+     | 
+------------------------------+----------+-------------+-----------+--------+ 
| Genworth Life Insurance      |        1 |    638,063  |     1.12% | A      | 
| Company                      |          |             |           |        | 
+------------------------------+----------+-------------+-----------+--------+ 
| Aviva Life and Annuity       |        2 |    417,974  |     0.73% | A      | 
| Company of NY                |          |             |           |        | 
+------------------------------+----------+-------------+-----------+--------+ 
| North American Company for L |        2 |    411,289  |     0.72% | A+     | 
| & H Insurance                |          |             |           |        | 
+------------------------------+----------+-------------+-----------+--------+ 
| Lincoln Benefit Life Company |        1 |    403,534  |     0.71% | A+     | 
+------------------------------+----------+-------------+-----------+--------+ 
| United of Omaha Life         |        2 |    295,251  |     0.52% | A+     | 
| Insurance Company            |          |             |           |        | 
+------------------------------+----------+-------------+-----------+--------+ 
| Sun Life Assurance Company   |        2 |    247,672  |     0.43% | A+     | 
| of CA                        |          |             |           |        | 
+------------------------------+----------+-------------+-----------+--------+ 
| ReliaStar Life Insurance     |        2 |    239,754  |     0.42% | A      | 
| Company                      |          |             |           |        | 
+------------------------------+----------+-------------+-----------+--------+ 
| Banner Life Insurance        |        2 |    227,886  |     0.40% | A+     | 
| Company                      |          |             |           |        | 
+------------------------------+----------+-------------+-----------+--------+ 
| ING Life Insurance and       |        2 |    209,604  |     0.37% | A      | 
| Annuity Company              |          |             |           |        | 
+------------------------------+----------+-------------+-----------+--------+ 
| MONY Life Insurance Company  |        1 |    194,221  |     0.34% | A+     | 
| of America                   |          |             |           |        | 
+------------------------------+----------+-------------+-----------+--------+ 
| Standard Insurance Company   |        1 |    149,885  |     0.26% | A      | 
+------------------------------+----------+-------------+-----------+--------+ 
| Security Mutual Life         |        1 |    147,154  |     0.26% | A      | 
| Insurance Company of NY      |          |             |           |        | 
+------------------------------+----------+-------------+-----------+--------+ 
| Reassure America Life        |        1 |    114,939  |     0.20% | A      | 
| Insurance Company            |          |             |           |        | 
+------------------------------+----------+-------------+-----------+--------+ 
| Phoenix Life Insurance       |        1 |     75,360  |     0.13% | B+     | 
| Company                      |          |             |           |        | 
+------------------------------+----------+-------------+-----------+--------+ 
| General American Life        |        1 |     61,055  |     0.11% | A+     | 
| Insurance Company            |          |             |           |        | 
+------------------------------+----------+-------------+-----------+--------+ 
| Beneficial Life Insurance    |        1 |     35,901  |     0.06% | A-     | 
| Company                      |          |             |           |        | 
+------------------------------+----------+-------------+-----------+--------+ 
|                              |          |             |           |        | 
+------------------------------+----------+-------------+-----------+--------+ 
|                              |          | 57,035,680  |    99.82% |        | 
+------------------------------+----------+-------------+-----------+--------+ 
 
 
+-------------------------------+---------+------------+-----------+ 
|                               |         |            |  Portion  | 
|                               | Nominal |Investment  |    of     | 
|                               |         |            |Portfolio  | 
+-------------------------------+---------+------------+-----------+ 
|                               |         |    GBP     |    %      | 
+-------------------------------+---------+------------+-----------+ 
| UK Treasury 4% 7 September    | 100,000 |    104,263 |     0.18% | 
| 2016                          |         |            |           | 
+-------------------------------+---------+------------+-----------+ 
|                               |         |    104,263 |     0.18% | 
+-------------------------------+---------+------------+-----------+ 
|                               |         |            |           | 
+-------------------------------+---------+------------+-----------+ 
| Portfolio Total               |         | 57,139,943 |   100.00% | 
+-------------------------------+---------+------------+-----------+ 
 
NOTES TO THE CONDENSED FINANCIAL STATEMENTS 
For the period from 1 September 2009 to 28 February 2010 
 
1              Principal activity 
The Company is a Guernsey registered closed-ended protected cell company 
established with one Cell known as the US Traded Life Interests Fund (the "Fund" 
or "Cell"). The redeemable participating preference shares (the "Shares") in the 
Company are listed on the London Stock Exchange. The Company's objective in 
respect of the Fund is to provide investors with an attractive capital return 
through investment predominantly in a diversified portfolio of U.S. Traded Life 
Interests ("TLIs"). 
 
2              Principal Accounting Policies 
(a) Basis of Preparation 
The condensed financial information for the six months ended 28 February 2010 
has been prepared in accordance with IAS 34 'Interim Financial Reporting'. The 
condensed interim financial information should be read in conjunction with the 
annual financial statements for the year ended 28 February 2010, which have been 
prepared in accordance with International Financial Reporting Standards. 
 
The accounting policies applied in the condensed financial statements are 
consistent with those of the annual financial statements for the period ended 31 
August 2009, as described in those financial statements. 
 
Critical accounting judgements and key sources of estimation uncertainty 
The preparation of financial statements in conformity with IFRS requires 
management to make judgements, estimates and assumptions that affect the 
application of policies and the reported amounts of assets and liabilities, 
income and expenses. The estimates and associated assumptions are based on 
historical experience and various other factors that are believed to be 
reasonable under the circumstances, the results of which form the basis of 
making judgements about the carrying values of assets and liabilities that are 
not readily apparent from other sources. Actual results may differ from these 
estimates. The estimates and underlying assumptions are reviewed on an ongoing 
basis. Revisions to accounting estimates are recognised in the year in which the 
estimate is revised if the revision affects only that period, or in the period 
of the revision and future periods if the revision affects both current and 
future periods. Where such judgements are made they are discussed below. 
 
(b) Valuation of investments 
The Company invests in US Traded Life Interests ("TLIs") which it intends to 
hold to maturity or until the end of the life of the Fund. All investments are 
classified as fair value through profit and loss. 
 
Recognition and basis of measurement 
Purchases of investments were recognised on a trade date basis and were 
initially measured at cost, being the consideration given. 
 
NOTES TO THE CONDENSED FINANCIAL STATEMENTS (CONTINUED) 
For the period from 1 September 2009 to 28 February 2010 
 
2              Principal Accounting Policies 
                (b) Valuation of investments (continued) 
 
Valuation 
The methodology adopted by the Directors is designed to reflect the fair value 
of the policies.  This methodology uses a discounted cash flow method. 
 
The value of a TLI policy is the present value of its expected net future cash 
flows. The calculation uses the following data and mortality rate assumptions 
provided by the Investment Manager: 
 
·      Death benefit payable under the policy; 
·      Premiums due under the policy; 
·      Mortality using the 2008 Valuation Basic Table (Ultimate) as adjusted by 
third party life expectancy assessments and using a 24-month "select period' 
adjustment; and 
·      A discount rate derived by the Investment Manager based on the US$ swap 
curve plus an appropriate risk premium for each period. 
 
There is inherent uncertainty within this mark to model basis of valuation that 
this valuation will differ from the realisable value of these investments were 
the TLIs to be sold at the balance sheet date. 
 
De-recognition 
The Company de-recognises a financial asset when the contractual rights to cash 
flows from the financial asset expire. A financial liability is de-recognised 
when the obligation specified in the contract is discharged, cancelled or 
expired. 
 
(c) Going concern 
The accounts have been prepared on the going concern basis. The Directors 
believe that this basis is appropriate as the Company has net assets 
significantly in excess of its liabilities. The bank loan (see note 12) was 
extended to 31 January 2011 on 24 February 2010. If the bank loan were to be 
recalled the Directors believe that the Company could realise sufficient assets 
over time in order to repay the loan, albeit at prices that would differ from 
their current balance sheet value. 
 
The Directors have reviewed the cash flow and projected income and expenses over 
the next twelve months and deemed that the Company has adequate financial 
resources to meet its obligations. 
 
+--+------------------------------+----+------------------+----------+----------+ 
| 3 | Interest and similar         |    |                  |          |          | 
|  | income                       |    |                  |          |          | 
+--+------------------------------+----+------------------+----------+----------+ 
|  |                              |    |         01.09.09 | 01.07.08 | 01.07.08 | 
+--+------------------------------+----+------------------+----------+----------+ 
|  |                              |    |               to |       to |       to | 
|  |                              |    |         28.02.10 | 31.12.08 | 31.08.09 | 
+--+------------------------------+----+------------------+----------+----------+ 
|  |                              |    |       GBP        |   GBP    |   GBP    | 
+--+------------------------------+----+------------------+----------+----------+ 
|  |                              |    |                  |          |          | 
+--+------------------------------+----+------------------+----------+----------+ 
|  |      Bank deposit interest   |    |             199  |  21,094  |   6,543  | 
+--+------------------------------+----+------------------+----------+----------+ 
|  |      Bond interest           |    |            1,779 |          |          | 
|  |                              |    |                  | -        | -        | 
+--+------------------------------+----+------------------+----------+----------+ 
|  |                              |    |                  |          |          | 
+--+------------------------------+----+------------------+----------+----------+ 
|  |      Total income            |    |            1,978 |  21,094  |   6,543  | 
+--+------------------------------+----+------------------+----------+----------+ 
 
NOTES TO THE CONDENSED FINANCIAL STATEMENTS (CONTINUED) 
For the period from 1 September 2009 to 28 February 2010 
 
4              Investment management and management fees 
SL Investment Management Limited ("SL"), the Investment Manager, was appointed 
under an agreement with the Company and other parties dated 16 March 2004, as 
amended and restated on 20 July 2004. The agreement may be terminated by either 
party giving not less than 12 months notice or shorter notice as the parties may 
agree to accept. 
 
With effect from 1 September 2009 the fee payable to the Investment Manager is 
0.475% per annum of the Company's Net Asset Value.  With effect from 1 April 
2012 the fee will be reduced to 0.4% per annum of the Company's Net Asset Value. 
 
 
RCM (UK) Limited, the Manager, was appointed under an agreement with the Company 
dated 16 March 2004 to manage the fixed interest and near cash assets of the 
Company in accordance with the investment policy and to implement the currency 
hedging facility from time to time approved by the Directors. Either party 
giving not less than 12 months notice may terminate the agreement. 
 
With effect from 1 September 2009 the fee payable to the Manager is 0.425% per 
annum of the Company's Net Asset Value.  With effect from 1 April 2012 the fee 
will be reduced to 0.4% per annum of the Company's Net Asset Value.  With effect 
from 1 September 2009 a separate Agreement was signed between the Company and 
the Manager for the provision of Administration and Secretarial Services at a 
fixed fee of GBP20,000 per annum. 
 
 
+--+------------------------------+----+----------+-------------------+----------+ 
| 5 |     Other expenses           |    |          |                   |          | 
+--+------------------------------+----+----------+-------------------+----------+ 
|  |                              |    | 01.09.09 |          01.07.08 | 01.07.08 | 
+--+------------------------------+----+----------+-------------------+----------+ 
|  |                              |    |       to |                to |       to | 
|  |                              |    | 28.02.10 |          31.12.08 | 31.08.09 | 
+--+------------------------------+----+----------+-------------------+----------+ 
|  |                              |    |   GBP    |        GBP        |   GBP    | 
+--+------------------------------+----+----------+-------------------+----------+ 
|  |                              |    |          |                   |          | 
+--+------------------------------+----+----------+-------------------+----------+ 
|  | Administration and           |    |   22,560 |           17,585  |  45,594  | 
|  | accountancy fees             |    |          |                   |          | 
+--+------------------------------+----+----------+-------------------+----------+ 
|  |     Broker fees              |    |   21,327 |            3,289  |  29,344  | 
+--+------------------------------+----+----------+-------------------+----------+ 
|  | Directors' fees and          |    |   32,261 |           21,906  |  50,993  | 
|  | expenses                     |    |          |                   |          | 
+--+------------------------------+----+----------+-------------------+----------+ 
|  |     D&O Insurance            |    |    4,354 |          11,262   |  12,408  | 
+--+------------------------------+----+----------+-------------------+----------+ 
|  |     Auditors' remuneration   |    |   25,861 |           18,272  |  31,249  | 
+--+------------------------------+----+----------+-------------------+----------+ 
|  |     Legal fees               |    |   22,276 |           18,873  | 203,370  | 
+--+------------------------------+----+----------+-------------------+----------+ 
|  |     Printing                 |    |      273 |            5,521  |   5,089  | 
+--+------------------------------+----+----------+-------------------+----------+ 
|  |     Safe custody fees        |    |    4,402 |            4,234  |  15,277  | 
+--+------------------------------+----+----------+-------------------+----------+ 
|  |     Bank fees and charges    |    |   11,808 |             4,748 |   58,484 | 
+--+------------------------------+----+----------+-------------------+----------+ 
|  |     Sundry expenses*         |    |   30,089 |           37,080  |  83,261  | 
+--+------------------------------+----+----------+-------------------+----------+ 
|  |                              |    |          |                   |          | 
+--+------------------------------+----+----------+-------------------+----------+ 
|  |                              |    |  175,211 |          138,022  | 535,069  | 
+--+------------------------------+----+----------+-------------------+----------+ 
 
*Sundry expenses include mailing services, tax exempt fees, registrar fees, 
stock exchange fees and other sundry costs. 
 
6              Taxation 
The Company is exempt from Guernsey Income Tax under the Income Tax (Exempt 
Bodies) (Guernsey) Ordinances 1989 and 1992 and is charged an annual exemption 
fee of GBP600 included in sundry expenses. 
 
The Company, as a collective investment scheme, will be able to continue to 
apply for exempt tax status under the revised company income tax regime that 
came into effect on 1 January 2008. 
 
NOTES TO THE CONDENSED FINANCIAL STATEMENTS (CONTINUED) 
For the period from 1 September 2009 to 28 February 2010 
 
6              Taxation (continued) 
Following an Extraordinary General Meeting on 28 August 2009, it was resolved 
that the Company would adopt UK tax residency from 1 September 2009 onwards. 
Since that date the Company has been managed in such a way as to meet the 
conditions for approval in due course as an investment trust under Section 842 
of the Income and Corporation Taxes Act 1988 in respect of the accounting period 
commencing on 1 September 2009. 
 
7              (Deficit) /Return per Share 
Revenue deficit per Share is based on the net deficit attributable to the Shares 
of GBP555,494 (December 2008: deficit GBP661,111, August 2009: deficit 
GBP1,524,889) and on the average number of Shares in issue of 40,000,000. 
Capital deficit per Share is based on the net capital deficit attributable to 
the Shares of GBP3,109,863 (December 2008: deficit GBP193,351, August 2009: 
return GBP213,780) and on the average number of Shares in issue of 40,000,000. 
 
8              Net Asset Value per Share 
The diluted and undiluted net asset value per Share is based on net assets 
attributable to Shares of GBP33,399,239 (December 2008: GBP37,518,243, August 
2009: GBP37,064,596) and on the 40,000,000 Shares in issue at the period end. 
 
+--+------------------------------+------+--------------+---------------+-------------+ 
| 9 |     Investments              |      |              |               |             | 
+--+------------------------------+------+--------------+---------------+-------------+ 
|  | (a) Investments at fair value       |              |               |             | 
|  | through profit or loss              |              |               |             | 
+--+-------------------------------------+--------------+---------------+-------------+ 
|  |                              |      |     01.09.09 |      01.07.08 |    01.07.08 | 
+--+------------------------------+------+--------------+---------------+-------------+ 
|  |                              |      |           to |            to |          to | 
|  |                              |      |     28.02.10 |      31.12.08 |    31.08.09 | 
+--+------------------------------+------+--------------+---------------+-------------+ 
|  |                              |      |     GBP      |      GBP      |    GBP      | 
+--+------------------------------+------+--------------+---------------+-------------+ 
|  |                              |      |              |               |             | 
+--+------------------------------+------+--------------+---------------+-------------+ 
|  |     Opening valuation        |      |   58,253,174 |   50,895,244  |  50,895,244 | 
+--+------------------------------+------+--------------+---------------+-------------+ 
|  |     Premiums paid            |      |    2,644,328 |     2,683,639 |   6,459,242 | 
+--+------------------------------+------+--------------+---------------+-------------+ 
|  |     Purchase of investments  |      |      105,430 |             - |           - | 
+--+------------------------------+------+--------------+---------------+-------------+ 
|  | Proceeds from the            |      |  (4,520,892) |   (4,610,915) | (9,586,000) | 
|  | maturities of investments    |      |              |               |             | 
+--+------------------------------+------+--------------+---------------+-------------+ 
|  | Realised gains on            |      |    2,723,148 |    2,670,192  |   4,664,216 | 
|  | maturities                   |      |              |               |             | 
+--+------------------------------+------+--------------+---------------+-------------+ 
|  | Unrealised movement in       |      |              |               |             | 
|  | (depreciation) /             |      |              |               |             | 
+--+------------------------------+------+--------------+---------------+-------------+ 
|  | appreciation on              |      | (2,065,245)  |    14,414,029 |   5,820,472 | 
|  | revaluation of  investments  |      |              |               |             | 
+--+------------------------------+------+--------------+---------------+-------------+ 
|  |                              |      |              |               |             | 
+--+------------------------------+------+--------------+---------------+-------------+ 
|  |     Closing valuation        |      |   57,139,943 |   66,051,919  | 58,253,174  | 
+--+------------------------------+------+--------------+---------------+-------------+ 
|  |                              |      |              |               |             | 
+--+------------------------------+------+--------------+---------------+-------------+ 
|  |     Comprising:-             |      |              |               |             | 
+--+------------------------------+------+--------------+---------------+-------------+ 
|  |     Closing book cost        |      |   57,666,591 |   55,919,765  | 56,714,577  | 
+--+------------------------------+------+--------------+---------------+-------------+ 
|  | Closing unrealised           |      |              |               |             | 
|  | (depreciation) /             |      |              |               |             | 
+--+------------------------------+------+--------------+---------------+-------------+ 
|  |     appreciation             |      |    (526,648) |    10,132,154 |   1,538,597 | 
+--+------------------------------+------+--------------+---------------+-------------+ 
|  |                              |      |              |               |             | 
+--+------------------------------+------+--------------+---------------+-------------+ 
|  |     Closing valuation        |      |   57,139,943 |   66,051,919  | 58,253,174  | 
+--+------------------------------+------+--------------+---------------+-------------+ 
|  |                              |      |              |               |             | 
+--+------------------------------+------+--------------+---------------+-------------+ 
 
NOTES TO THE CONDENSED FINANCIAL STATEMENTS (CONTINUED) 
For the period from 1 September 2009 to 28 February 2010 
 
9.Investments (continued) 
 
+--+------------------------------+------+-------------+---------------+-------------+ 
|  | (b) Net gain/(loss) on       |      |    01.09.09 |      01.07.08 |    01.07.08 | 
|  | investments held             |      |             |               |             | 
+--+------------------------------+------+-------------+---------------+-------------+ 
|  | at fair value through profit |      |          to |            to |          to | 
|  | or loss                      |      |    28.02.10 |      31.12.08 |    31.08.09 | 
+--+------------------------------+------+-------------+---------------+-------------+ 
|  |                              |      |    GBP      |      GBP      |    GBP      | 
+--+------------------------------+------+-------------+---------------+-------------+ 
|  |                              |      |             |               |             | 
+--+------------------------------+------+-------------+---------------+-------------+ 
|  | Realised gain on maturities  |      |   2,723,148 |    2,670,192  |  4,664,216  | 
+--+------------------------------+------+-------------+---------------+-------------+ 
|  |                              |      |             |               |             | 
+--+------------------------------+------+-------------+---------------+-------------+ 
|  | Unrealised movement in       |      |             |               |             | 
+--+------------------------------+------+-------------+---------------+-------------+ 
|  | (depreciation)/appreciation  |      | (2,065,245) |    14,414,029 |   5,820,472 | 
|  | on revaluation of            |      |             |               |             | 
|  | investments                  |      |             |               |             | 
+--+------------------------------+------+-------------+---------------+-------------+ 
|  |                              |      |             |               |             | 
+--+------------------------------+------+-------------+---------------+-------------+ 
|  |                              |      |     657,903 |   17,084,221  |  10,484,688 | 
+--+------------------------------+------+-------------+---------------+-------------+ 
 
+--+------------------------------+------+----------+------------+------------+ 
| 10 | Other receivables            |      |          |            |            | 
+--+------------------------------+------+----------+------------+------------+ 
|  |                              |      |28.02.10  |  31.12.08  |  31.08.09  | 
+--+------------------------------+------+----------+------------+------------+ 
|  |                              |      |   GBP    |    GBP     |    GBP     | 
+--+------------------------------+------+----------+------------+------------+ 
|  |                              |      |          |            |            | 
+--+------------------------------+------+----------+------------+------------+ 
|  | Sundry debtors               |      |   15,640 |     2,879  |    11,348  | 
+--+------------------------------+------+----------+------------+------------+ 
|  | Maturity proceeds receivable |      |        - | 4,101,442  | 4,609,711  | 
+--+------------------------------+------+----------+------------+------------+ 
|  | Accrued income               |      |    1,901 |       194  |          - | 
|  |                              |      |          |            |            | 
+--+------------------------------+------+----------+------------+------------+ 
|  |                              |      |          |            |            | 
+--+------------------------------+------+----------+------------+------------+ 
|  |                              |      |   17,541 | 4,104,515  | 4,621,059  | 
+--+------------------------------+------+----------+------------+------------+ 
 
 
+--+------------------------------+------+----------+----------+----------+ 
| 11 |     Other payables           |      |          |          |          | 
+--+------------------------------+------+----------+----------+----------+ 
|  |                              |      |28.02.10  |31.12.08  |31.08.09  | 
+--+------------------------------+------+----------+----------+----------+ 
|  |                              |      |   GBP    |   GBP    |   GBP    | 
+--+------------------------------+------+----------+----------+----------+ 
|  |                              |      |          |          |          | 
+--+------------------------------+------+----------+----------+----------+ 
|  |     Accrued expenses         |      |  174,728 | 207,209  | 435,398  | 
+--+------------------------------+------+----------+----------+----------+ 
|  |                              |      |          |          |          | 
+--+------------------------------+------+----------+----------+----------+ 
|  |                              |      |  174,728 | 207,209  | 435,398  | 
+--+------------------------------+------+----------+----------+----------+ 
 
12            Loan facility 
The Company has in place a loan agreement, dated 16 March 2009, with Allied 
Irish Banks plc.  Under this agreement the Company initially borrowed US$28 
million as an amortising term loan and could borrow up to US$10 million under a 
revolving credit facility.  As of 31 August 2009, the balances outstanding were 
US$28 million and US$5,447,000 respectively.  (As of 31 December 2008 total 
borrowings had amounted to US$32 million under a previous agreement with Allied 
Irish Banks plc. 
 
Since this loan agreement was due to expire on 16 March 2010, on 24 February 
2010 it was extended to 31 January 2011 and the US$ 10 million revolving credit 
facility renewed.  By 28 February 2010, the balance on the amortising term loan 
had fallen to US$23,156,000 and US$2 million had been drawn down under the 
revolving credit facility. 
 
The extension and renewal of the agreement did not involve any significant 
changes to its terms and conditions. Interest is payable on outstanding balances 
at LIBOR plus 2% in relation to the amortising term loan and at LIBOR plus 2.5% 
in relation the revolving credit facility. 
 
NOTES TO THE CONDENSED FINANCIAL STATEMENTS (CONTINUED) 
For the period from 1 September 2009 to 28 February 2010 
 
12            Loan facility (continued) 
It is the Company's intention to repay all loans with proceeds from the maturity 
of TLIs, but were it necessary, the Company could sell TLIs in order to repay 
these loans. It is noted that the valuation methodology does not assume sales of 
TLIs, rather that they would be held to maturity. In the event of a sale, the 
proceeds received would in all likelihood be lower than the valuation. 
 
 
+--+------------------------------+------------+--------------+-------------+--------------+ 
| 13 |     Reserves                 |            |              |             |              | 
+--+------------------------------+------------+--------------+-------------+--------------+ 
|  |                              |          Capital          |  Revenue    |              | 
|  |                              |          Reserve          |             |              | 
+--+------------------------------+---------------------------+-------------+--------------+ 
|  |                              |   Realised |  Unrealised  |  Reserves   |    Total     | 
+--+------------------------------+------------+--------------+-------------+--------------+ 
|  |                              |   28.02.10 |  28.02.10    |  28.02.10   |  28.02.10    | 
+--+------------------------------+------------+--------------+-------------+--------------+ 
|  |                              |    GBP     |     GBP      |    GBP      |     GBP      | 
+--+------------------------------+------------+--------------+-------------+--------------+ 
|  |                              |            |              |             |              | 
+--+------------------------------+------------+--------------+-------------+--------------+ 
|  |     Opening balance          |  8,329,265 |  (5,940,372) | (4,492,533) |  (2,103,640) | 
+--+------------------------------+------------+--------------+-------------+--------------+ 
|  | Realised gain on             |  2,723,148 |            - |       -     |    2,723,148 | 
|  | maturities                   |            |              |             |              | 
+--+------------------------------+------------+--------------+-------------+--------------+ 
|  | Movement in unrealised       |          - |  (2,065,245) |       -     |  (2,065,245) | 
|  | depreciation on              |            |              |             |              | 
|  | investments                  |            |              |             |              | 
+--+------------------------------+------------+--------------+-------------+--------------+ 
|  | Movement in unrealised       |          - |  (3,000,191) |           - |  (3,000,191) | 
|  | currency loss on             |            |              |             |              | 
|  | forward foreign currency     |            |              |             |              | 
|  | contracts                    |            |              |             |              | 
+--+------------------------------+------------+--------------+-------------+--------------+ 
|  | Movement in unrealised       |          - |    (767,575) |           - |    (767,575) | 
|  | currency losses              |            |              |             |              | 
+--+------------------------------+------------+--------------+-------------+--------------+ 
|  | Revenue deficit for the      |          - |            - |   (555,494) | (555,494)    | 
|  | period                       |            |              |             |              | 
+--+------------------------------+------------+--------------+-------------+--------------+ 
|  |                              |            |              |             |              | 
+--+------------------------------+------------+--------------+-------------+--------------+ 
|  |     Closing balance          | 11,052,413 | (11,773,383) | (5,048,027) |  (5,768,997) | 
+--+------------------------------+------------+--------------+-------------+--------------+ 
|  |                              |            |              |             |              | 
+--+------------------------------+------------+--------------+-------------+--------------+ 
 
+--+------------------------------+-----------+--------------+-------------+--------------+ 
|  |                              |         Capital          |     Revenue |              | 
|  |                              |         Reserve          |             |              | 
+--+------------------------------+--------------------------+-------------+--------------+ 
|  |                              | Realised  |  Unrealised  |  Reserves   |    Total     | 
+--+------------------------------+-----------+--------------+-------------+--------------+ 
|  |                              | 31.12.08  |  31.12.08    |  31.12.08   |  31.12.08    | 
+--+------------------------------+-----------+--------------+-------------+--------------+ 
|  |                              |    GBP    |     GBP      |    GBP      |     GBP      | 
+--+------------------------------+-----------+--------------+-------------+--------------+ 
|  |                              |           |              |             |              | 
+--+------------------------------+-----------+--------------+-------------+--------------+ 
|  |     Opening balance          | 3,665,049 |  (1,489,936) | (2,967,644) |    (792,531) | 
+--+------------------------------+-----------+--------------+-------------+--------------+ 
|  | Realised gain on             | 2,670,192 |            - |       -     |    2,670,192 | 
|  | maturities                   |           |              |             |              | 
+--+------------------------------+-----------+--------------+-------------+--------------+ 
|  | Movement in unrealised       |         - |   14,414,029 |       -     |   14,414,029 | 
|  | appreciation on              |           |              |             |              | 
|  | investments                  |           |              |             |              | 
+--+------------------------------+-----------+--------------+-------------+--------------+ 
|  | Movement in unrealised       |         - | (12,258,951) |           - | (12,258,951) | 
|  | currency loss on             |           |              |             |              | 
|  | forward foreign currency     |           |              |             |              | 
|  | contracts                    |           |              |             |              | 
+--+------------------------------+-----------+--------------+-------------+--------------+ 
|  | Movement in unrealised       |         - |  (5,021,621) |           - |  (5,021,621) | 
|  | currency losses              |           |              |             |              | 
+--+------------------------------+-----------+--------------+-------------+--------------+ 
|  | Revenue deficit for the      |         - |            - |   (661,111) | (661,111)    | 
|  | period                       |           |              |             |              | 
+--+------------------------------+-----------+--------------+-------------+--------------+ 
|  |                              |           |              |             |              | 
+--+------------------------------+-----------+--------------+-------------+--------------+ 
|  |     Closing balance          | 6,335,241 |  (4,346,479) | (3,628,755) |  (1,649,993) | 
+--+------------------------------+-----------+--------------+-------------+--------------+ 
|  |                              |           |              |             |              | 
+--+------------------------------+-----------+--------------+-------------+--------------+ 
NOTES TO THE CONDENSED FINANCIAL STATEMENTS (CONTINUED) 
For the period 1 September 2009 to 28 February 2010 
 
+--+------------------------------+-----------+-------------+-------------+----------------+ 
| 13| Reserves (continued)         |           |             |             |                | 
+--+------------------------------+-----------+-------------+-------------+----------------+ 
|  |                              |        Capital          |     Revenue |                | 
|  |                              |        Reserve          |             |                | 
+--+------------------------------+-------------------------+-------------+----------------+ 
|  |                              | Realised  | Unrealised  |  Reserves   |     Total      | 
+--+------------------------------+-----------+-------------+-------------+----------------+ 
|  |                              | 31.12.09  |  31.12.09   |  31.12.09   |    31.12.09    | 
+--+------------------------------+-----------+-------------+-------------+----------------+ 
|  |                              |    GBP    |    GBP      |    GBP      |      GBP       | 
+--+------------------------------+-----------+-------------+-------------+----------------+ 
|  |                              |           |             |             |                | 
+--+------------------------------+-----------+-------------+-------------+----------------+ 
|  |     Opening balance          | 3,665,049 | (1,489,936) | (2,967,644) |      (792,531) | 
+--+------------------------------+-----------+-------------+-------------+----------------+ 
|  | Realised gain on             | 4,664,216 |           - |       -     |      4,664,216 | 
|  | maturities                   |           |             |             |                | 
+--+------------------------------+-----------+-------------+-------------+----------------+ 
|  | Movement in unrealised       |         - |   5,820,472 |       -     |      5,820,472 | 
|  | appreciation on              |           |             |             |                | 
|  | investments                  |           |             |             |                | 
+--+------------------------------+-----------+-------------+-------------+----------------+ 
|  | Movement in unrealised       |         - | (7,025,749) |           - |    (7,025,749) | 
|  | currency loss on             |           |             |             |                | 
|  | forward foreign currency     |           |             |             |                | 
|  | contracts                    |           |             |             |                | 
+--+------------------------------+-----------+-------------+-------------+----------------+ 
|  | Movement in unrealised       |         - | (3,245,159) |           - |    (3,245,159) | 
|  | currency losses              |           |             |             |                | 
+--+------------------------------+-----------+-------------+-------------+----------------+ 
|  | Revenue deficit for the      |         - |           - | (1,524,889) | (1,524,889)    | 
|  | period                       |           |             |             |                | 
+--+------------------------------+-----------+-------------+-------------+----------------+ 
|  |                              |           |             |             |                | 
+--+------------------------------+-----------+-------------+-------------+----------------+ 
|  |     Closing balance          | 8,329,265 | (5,940,372) | (4,492,533) |    (2,103,640) | 
+--+------------------------------+-----------+-------------+-------------+----------------+ 
 
 
14           Related party transactions 
Fees earned by the Directors of the Company during the period were GBP31,397 of 
which GBP10,538 was outstanding at the period end (December 2008: GBP21,530 of 
which GBPnil was outstanding at the period end, August 2009: (14 months): 
GBP49,584 of which GBP7,083 was outstanding at the period end). 
 
15           Forward currency contracts 
The forward foreign exchange contracts in place have resulted in a balance of 
unrealised foreign exchange loss of GBP8,720,808 at the period end (December 
2008: GBP10,953,819 loss, August 2009: GBP5,720,617 loss). As a result the 
movement in unrealised foreign exchange loss on forward contracts during the 
period was a loss of GBP3,000,191 (December 2008: GBP12,258,951 loss, August 
2009: GBP7,025,749 loss), which is included under 'Other foreign exchange 
losses' on the face of the Condensed Income Statement. 
 
The Company also incurred currency foreign exchange losses during the period of 
GBP767,575 (December 2008: GBP5,021,621, August 2009 GBP3,245,159 loss).  These 
losses arose predominantly on the revaluation of the Company's US$ denominated 
borrowings (see Note 12) and are also included under 'Other foreign exchange 
losses' on the face of the Condensed Income Statement. 
 
In total, the Company incurred foreign exchange losses of GBP3,767,766 (December 
2008: GBP17,280,572 loss, August 2009: GBP10,270,908 loss). These losses are 
offset by the foreign exchange gain made on the underlying portfolio of TLI 
policies. 
 
This information is provided by RNS 
            The company news service from the London Stock Exchange 
   END 
 
 IR PGUUUCUPUGQU 
 

Alternative Asset Opps Pcc (LSE:TLI)
Historical Stock Chart
From Jun 2024 to Jul 2024 Click Here for more Alternative Asset Opps Pcc Charts.
Alternative Asset Opps Pcc (LSE:TLI)
Historical Stock Chart
From Jul 2023 to Jul 2024 Click Here for more Alternative Asset Opps Pcc Charts.